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Abbreviations
pR, proteorhodopsin; bR, baceriorhodopsin; OG, β-octyl-D-glucoside; PMSF,
phenylmethylsulphonyl fluoride; AMP, ampicillin; SDS-PAGE, sodium dodecyl
sulfate polyacrylamide

Introduction
Proteorhodopsin (pR), a homologue of archaeal bacteriorhodopsin (bR), is a 249amino-acid, seven-helix, transmembrane protein bound to a retinal molecule that
functions as a light-driven proton pump. The retinal chromophore of pR absorbs
a photon and isomerizes, which induces conformational changes in the protein
structure [1]. Proteorhodopsin was discovered in the year 2000 from the DNA
sequences of several uncultured species of marine γ-proteobacteria, which is a
component of marine planktons present in ocean surface water [2, 3]. Since the
discovery of pR, additional studies have found that pR is widely distributed in the
world. In fact, it has been projected that 1028 light-driven pR expressing bacteria
exist in the world [4, 5]. Proteorhodopsin is believed to play an important role in
the energy balance of the Earth due the large marine biomass of bacterioplanktons
[6].

Understanding the structure of pR, along with the major active site amino acid
residues, will help us explore the important functions of this protein. The
majority of active site amino acid residues as well as the amino acid residues that
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form retinal binding pockets in archaeal bacteriorhodopsin are also highly
conserved in pR [2]. Like bacteriorhodopsin, pR has conserved arginine,
aspartate, and lysine residues, which are important in the proton transport
mechanism. Specifically, the active site residues Arg82, Asp85, Asp212, and Lys216
in bR are conserved as Arg94, Asp97, Asp227, and Lys231 in pR [7]. Furthermore,
the retinal chromophore of pR covalently binds as a protonated Schiff’s base at
Lys231, while Asp97 plays a significant role in proton transfer from the
photoactivated retinal as it is the primary proton acceptor [2, 7].

The ultimate goal of this project is to form a crystallized pR in order to obtain a
well-defined three-dimensional structure, which is essential to enhance and
facilitate a greater understanding between the structure of pR and its function.
Furthermore, an understanding of the purification procedures of pR could provide
better methods for purifying and crystallizing other transmembrane proteins, in
particular G protein-coupled receptors. Crystallization requires a high protein
purity of approximately 95% or greater.

Proteorhodopsin had been previously purified with affinity chromatography using
Phenylsepharose™, hydroxyapatite and/or Ni-NTA resin [8, 9]. However, the
last technique requires pR to be cloned into the pBAD-TOPO vector with a 6xHig
-tag at the C-terminus [2]. The use of columns also requires substantial cost and
time, especially for purifying quantities of more than ~ 1-5 mg. Previously, it was
shown that proteorhodopsin (pR) is selectively precipitated using 100mM citrate
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pH 5.5 containing 3% octyl-glucoside [6]. Applying this method, we have been
able to precipitate pR selectively from a detergent extract of E. coli cells. In fact,
this method alone yields a pR purity typically approaching 32%. The current
experiments mainly concentrate on establishing an optimized purification pR
yield by controlling specific conditions such as concentration, solubility, pH, and
pR-specific precipitating agent. Most important, we determined that phosphate
helps with selectively precipitating the impurities from pR, and its use thereby can
increase the purity of pR. We systematically explored the optimal concentrations
of phosphate, citrate, and octylglucoside to obtain with the most favorable higher
pR purity than has ever previously been obtained without the use of column
purification methods, i.e. in excess of 50% purity.

Methods

Enriched Luria-Bertani (LB) Media
We added 10 g of Bacto Tryptone, 5 g of Yeast Extract, 6 g of sodium
phosphate monobasic (NaH2PO4⋅H2O), 8.7 g of potassium phosphate dibasic
(K2HPO4) and 10 mL of glycerol per 1-liter of distilled water into a beaker. After
dissolving, concentrated NaOH was used to adjust the pH to 7. Once made, the
solution was sterilized by autoclaving (15 min) and then stored in a cold room
(approximately 4°C).

4

Protein Expression
Proteorhodopsin was expressed in E. coli strain UT5600 using a pBAD TOPO
plasmid [6]. 1 mL of LB media was transferred into a small tube along with 50
µg/mL of ampicillin. Then, an average-size transfected E. coli colony was
collected with a sterile pipette tip and transferred into the 1 mL of LB/Amp
media, which was then incubated overnight at 37°C. This starter culture was
transferred into a flask that contains 500 mL enriched LB media containing 50
µg/mL ampicillin. The flask was placed in the shaker bath at 37°C for
approximately 4-5 hours. After 4-5 hours of growth, the heater was turned off
and the flask was cooled quickly to room temperature, using a bucket of ice added
to the shaker bath. Once the temperature reached ~20°C, 1/100 volume of 20%
L-arabionose was added, along with ~10 µg/liter of all trans-retinal dissolved in
acetone. The flask remained shaking (~30 rpm) in the shaker bath overnight in a
dark room at 15-20°C. The flask was then moved to the cold room and left
overnight (without shaking).

Cell Harvest
The cells were collected by 30 min of centrifugation at 6000 rpm (Beckman JA10 rotor). The supernatant usually immediately separated from the pellet. We
determined the wet weight of the pellet by taring an empty centrifuge tube, then
weighing it along with the pellet formed by centrifugation.
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Cell Lysis
The pellet was completely resuspended in approximately 5x volume of lysis
buffer (10 mM HEPES pH 7.1 containing 1 mM PMSF protease inhibitor, 3% βoctyl-D-glucoside, 0.08% lysozyme and 0.01 mg/mL DNAse). The lysed cells in
lysis buffer were centrifuged at 3900 rpm in Beckman tabletop centrifuge at
4°C using GA-6 rotor. The reddish colored supernatant was immediately
separated from the pellets. If the pellets were still colored pinkish, then the pellets
were re-extracted in lysis buffer. Ultimately, the grayish pellet containing
impurities, i.e. undesired proteins, was discarded, and colored supernatants were
combined. This combined solution is referred to as raw detergent extract of E.
coli.

pR Purification
1/3 volume of 100 mM sodium citrate pH 5.5 was added to the raw detergent
extract and then left to sit for 15 minutes. The solution was then spun down for
15-30 minutes at 3900 rpm at 4°C. If any white pellet was obtained at this time,
these impurities were discarded; the colored supernatant was separated from the
impurities, and another 1/3 volume of 100 mM sodium citrate was added to the
colored supernatant. The centrifugation was repeated, and any colored pellets
were saved; the supernatant was further diluted each time until the supernatant
became nearly colorless. All the pink-colored pellets obtained from the previous

6
citrate steps were recombined by solubilizing into a minimal (~50µL) volume of
50 mM Tris-Cl pH 9.0 containing 3% OG. Once the pellets were completely
resuspended, they were centrifuged (15 min, 3900 rpm). The supernatants were
then transferred to a new tube and any pelleted impurities were discarded. A
UV/Visible spectrometry measurement determined the degree of purity at this
particular stage.

The colored supernatant was then repelleted using the citrate precipitation
methods described above. Any remaining colored supernatant was repeatedly
precipitated by further addition of 100 mM citrate, until all the color was
transferred from the supernatant to pellets. We made sure to save any colored
pellets while removing impurities. Once the supernatant became clear in color,
we recombined all the colored pellets by solubilizing them into a small volume of
50 mM Tris-Cl pH 9.0 containing 3% OG, and spun it down. Again separating
the pink-colored pR-containing supernatant from impurities in the colorless pellet.
Afterwards, we saved 50 µl of pR solubilized in Tris-Cl for additional UV/Visible
spectrometry measurements.

Use of Phosphate as a Citrate competitor in Purification
After two full cycles of citrate-induced precipitation and resolubilization in 3%
OG Tris pH 9.0, we added 1/3 volume of 600 mM phosphate, 30 mM sodium
citrate pH 5.5, containing 0.4% OG, and incubated for 15 minutes at room
temperature. Then, we spun it down for 15 minutes at 3900 rpm at 4°C. If any
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impurities were precipitated, they were discarded. Then a similar volume of 30
mM citrate/ 600 mM phosphate pH 5.5, containing 0.4% OG, was added,
followed by centrifugation. The addition citrate/phosphate/OG solution, followed
by centrifugation, was repeated until the pR precipitated out of solution as a
colored pellet. Once a pR pellet was obtained, the supernatant was further diluted
with 10 mM citrate pH 5.5 containing 0.4% OG alone (without phosphate), until
the supernatant became nearly colorless. All the colored pellets were recombined
by solubilizing them into a small volume of 50 mM Tris-Cl pH 9.0 with 3% OG
and was again spun down. The pink-colored supernatant was separated and
collected from any impurities. 50 µl of pR solubilized in Tris-Cl was saved for
UV/Visible spectrometry measurements. pR was reproduced from the colored
supernatant using a combination of citrate and phosphate precipitation method
described above.

Absorption Spectroscopy
Absorption spectra were measured on a Shimadzu UV-265 spectrophotometer at
2nm resolution over the range 700-250 nm. A sample volume of 0.6ml was used
in a masked quartz micro cuvette for all measurements. An absorbance ratio
A280:A520 of ~2.0 indicates 100% pure pR, as shown previously [9].
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Result and Discussion
Purification of pR with Citrate Precipitation

Figure 1. UV/Visible Absorption Spectra of pR in 50 mM Tris-Cl pH 9.1 containing 3%
octylglucoside solution at three rounds of purification. All spectra were measured in the
presence of OG at pH 9.1. Green Spectra indicates the preliminary purification of pR using 100
mM citrate pH 5.5; Purple Spectra indicates the second round of the same method; Red, spectra
for the first pellet treated with 30 mM citrate pH 5.5 resuspended in Tris; Blue, the same method –
30 mM citrate pH 5.5 – was applied.

As shown in Figure 1, the preliminary purification of pR using 100 mM citrate pH
5.5 yielded approximately 11:1 ratio of A280:A520. The same method of
purification with 100 mM citrate was repeated for the second round resulting in
approximately 6:1 absorbance ratio. Within two rounds of 100 mM citrate
precipitation, we were able to purify pR and reduce the ratio from 11:1 to 6:1.
After two full cycles of citrate, pR was treated with 30 mM citrate pH 5.5
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containing 0.4% OG, in which we measured the UV spectra of pellets separately,
instead of combining them, at each addition of citrate. The ratio of the first pellet
in Tris was nearly 3:1 while the second pellet in Tris was 4:1 (Figure 1). The
color of pellets at this stage was very bright with high intensity in pR pellets. The
result indicates that a high concentration of citrate already had precipitated the
impurities as well as other undesired proteins by citrate binding to numerous
proteins. The color also indicates that pR has one or more binding sites for
citrate; thus, a lower concentration of citrate is enough to specifically bind pR to
precipitate more effectively once the impurities are removed.

Finding a Better Concentration of Citrate in the Presence of 600mM Phosphate
After a few rounds of citrate precipitation including both 100 mM concentration
and a lower concentration, pR was treated with 30 mM citrate and 600 mM
phosphate pH 5.5 containing 0.4% OG. This particular concentration of
phosphate along with citrate brings down more impurities, while leaving pR
solubilitzed. We believe that phosphate prevents precipitation by competing for
the citrate binding site, thereby blocking citrate-induced aggregation. This
particular method could be a good transition in purification as it removes more
impurities and increases the purity of pR. In the presence at constant 600 mM
concentration of phosphate, we attempted to explore a better concentration of
citrate. The goal was to find the lowest citrate concentration that can induce
aggregation in the presence of phosphate.
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Figure 2. UV/Visible Absorption Spectra of pR resuspended in Tris-Cl pH 9.1 with 3% OG
after treated with different concentrations of citrate at pH 5.5 while have the same 600 mM
phosphate present. Purple Spectra indicates pR treated with 65 mM citrate; Green, 30 mM
citrate; Red, 15 mM citrate.

We tested three different citrate concentrations – 65 mM, 30 mM and 15 mM – at
pH 5.5 with the presence of 600 mM phosphate. Among different concentrations,
the ratio of A280:A520 of 30 mM citrate along with 600 mM phosphate gave
approximately 3:1, one of the best purity levels we have ever obtained in the
laboratory without columns, while 65 mM and 15 mM both yielded
approximately 4:1 ratio (Figure 2). It was interesting to note that 30 mM, which
is neither the lowest nor the highest concentration of citrate, could bring down the
pR to the highest purity level so far achieved.
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Based on these results we investigated the most favorable conditions that would
increase the degree of purity of pR and have the ability to recover pR in high
yield. We examined several different ways of purification of pR after a few
rounds of purification steps with both 100 mM and 30 mM citrate pH 5.5.

Use of Phosphate in pR Purification
We tried using 600 mM phosphate with 30 mM citrate pH 5.5 containing 0.4%
OG, only without switching back to citrate alone after 2-3 citrate precipitation
rounds. Using a mixture of citrate and phosphate, we were able to remove more
impurities, and then precipitated pR. The pellets were resuspended in Tris for the
UV spectra measurements. The first pellet in Tris resulted approximately 7:1
ratio of purity, whereas a ratio of the second and third pellets in Tris diminished to
4:1 and 3:1 respectively (Figure 3). As more volume of phosphate along with
citrate was added, we were able to obtain purer pellets. However, one problem
that occurred in this particular method was that it was difficult to recover the pR
completely, meaning there was still color left in the supernatant and we were not
able to completely bring the color down into a pellet. This might suggest that 600
mM phosphate may be too high in pR precipitation, as the binding sites may have
been occupied by phosphate; thus, phosphate blocks citrate-induced aggregation.
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Figure 3. UV/Visible Absorption Spectra of pR in 50 mM Tris-Cl pH 9.1 containing 3% OG
at 30 mM citrate and 600 mM phosphate pH 5.5 w/ 0.4% OG purification. Blue, first
precipitated pR pellet in Tris; Green, second pR pellet obtained; Red, third precipitation of pR
pellet resuspended in Tris for spectrum. There was still color left in the supernatant even after
third precipitation and could not complete reproducing pR.

Use of a Lower Concentration of Citrate Alone
After the preliminary citrate precipitation procedures including both 100 mM and
30 mM citrate at pH 5.5, we tried an even lower concentration of citrate, 10 mM
citrate pH 5.5 containing 0.4% OG, in a small amount of pR in Tris and repeated
the same addition/centrifugation procedure steps. The low concentration of
citrate precipitation without any phosphate maintained approximately a 4:1 ratio
of pR purity at the first addition of 10 mM citrate. In the second addition, we
brought all the color down from the solution into a pellet; the purity of the pellet
was increased to 6:1 due to a precipitation of pR, even with other undesired
proteins (Figure 4).
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Figure 4. UV Spectra of pR resuspended in Tris-Cl pH 9.1 w/ 3% OG after 10 mM citrate
pH 5.5 containing 0.4% precipitation. Red, first precipitation; Purple, second precipitation of
pR that had precipitated all color into a pallet from the supernatant.

Alternating Treatment with Citrate Alone and with both Citrate and Phosphate
The results from applications of 30 mM citrate and 600 mM phosphate and 10
mM citrate alone has led us to treat pR with 30 mM citrate and 600 mM
phosphate pH 5.5 contaning 0.4% OG first after the preliminary citrate
precipitation, and then switching to 10 mM citrate pH 5.5 containing 0.4% OG,
and vice versa.
pR that was initially treated with a mixture of citrate and phosphate resulted in
approximately 7:1 A280:A520 ratio. Once the first pR pellet was obtained from
citrate and phosphate solution, we treated pR with 10 mM citrate alone without
having phosphate in the solution. The second pellet obtained from addition of 10
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mM citrate pH 5.5 containing 0.4% OG reduced the purity down to 5:1. Finally,
the third pR pellet treated with 10 mM citrate pH 5.5 was the last pellet
precipitated, which brought all the color from the supernatant down; the purity of
third pR pellet decreased as the ratio rose to 6:1 ratio of purity (Figure 5).

Figure 5. UV spectra of pR, which was initially treated with 30 mM citrate along with 600
mM phosphate then switched to 10 mM citrate alone, resuspended in 50 mM Tris-Cl pH 9.1
containing 3% OG. Red, spectra of pR precipitated from use of citrate and phosphate; Green, pR
pellet precipitated from 10 mM citrate after switched from citrate and phosphate solution; Purple,
second pR pellet obtained from 10 mM citrate precipitation.

Moreover, we tried reversing the order of steps. We initially treated with 10 mM
citrate pH 5.5 containing 0.4% OG, and then switched to 30 mM citrate and 600
mM phosphate pH 5.5 with 0.4% OG. This method was problematic because it
was difficult to precipitate pR completely in the presence of phosphate. We tested
the idea of raising the concentration of citrate, which would allow to compete
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with phosphate as it would precipitate pR. The difficulty in recovering pR was
finally solved by gradually reducing the citrate and phosphate concentrations,
while keeping OG concentration constant. We added 400 mM citrate and 600
mM phosphate pH 5.5 containing 0.4% OG. Then we added an equal volume of
0.4% OG solution itself and let it sit over a long period of time (~10 days). The
constant OG concentration, with a high concentration of citrate, selectively
precipitated pR. The UV absorption spectrum indicated that the ratio of purity
was nearly 5:2, which was the best result obtained to date (Figure 6), and likely
indicative of a final pR purity level of ~50% of protein by weight.
Overall, the use of phosphate along with citrate is promising in pR purification.
This particular purification procedure has brought us a step closer in achieving
crystallization through efficient use of inexpensive materials.
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Figure 6. UV/Visible Spectrum of pR, which has been precipitated from 400 mM citrate and
600 mM phosphate pH 5.5 containing >0.4% OG, dissolved in 50 mM Tris-Cl pH 9.1 w/ 3%
OG. The spectrum indicates a purity of pR after the pR purification in alternating 10 mM citrate
pH 5.5 w/ 0.4% OG and 400 mM citrate and 600 mM phosphate pH 5.5 w/ > 0.4% OG.

Phosphate and pKa value
During this whole project, I have noticed one very interesting result. When I
added 30 mM citrate and 600 mM phosphate pH 5.5 containing 0.4% OG into pR
resuspended in 50mM Tris-Cl pH 9.1 with 3% OG, the color clearly changes from
reddish to purple (Figure 7).
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Figure 7. The color shift in pR depends on the presence of phosphate. Left, 10 mM citrate pH
5.5 containing 0.4% OG added into pR dissolved in 50 mM Tris-Cl pH 9.1 containing 3% OG;
Right, 30 mM citrate and 600 mM phosphate pH 5.5 containing 0.4% OG added into pR
resuspended in 50 mM Tris-Cl pH 9.1 containing 3% OG.

That is, the color of pR is red at basic pH (Tris-Cl pH 9.1 containing 3% OG).
When we added citrate, pH 5.5 to such a pH 9 solution, there was no notable
change in the color of pR. However, a different result was obtained when 30 mM
citrate and 600 mM phosphate pH 5.5 was added into the same pR sample,
originally at pH 9. When the mixture of citrate and phosphate was added into pR,
the color consistently turned into an intense purple and was clearly
distinguishable from the color of pR that was phosphate-free though they were at
similar pH levels (Figure 8 Left). Then, subsequent switching of the solutions,
i.e. addition of phosphate into the solution that originally had citrate only, yielded
the same intense purple color (Figure 8 Right). This indicates that phosphate
could raise the pKa value of pR, which is due to the titration of Asp97 the
chromophore’s counter ion.
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Figure 8. Comparison in color of pR with the presence of phosphate and without phosphate.
Left, 10 mM citrate pH 5.5 containing 0.4% OG is added into pR dissolved in 50 mM Tris-Cl pH
9.1 w/ 0.4% OG on the left, whereas 30 mM citrate and 600 mM phosphate pH 5.5 containg 0.4%
OG is added into pR dissolved in Tris on the right; Right, a solution of citrate and phosphate is
added into pR on the left while 10 mM citrate is added into pR instead of a mixture of phosphate
and citrate on the right.
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Summary

Proteorhodopsin (pR) is a transmembrane protein bound to a retinal molecule that
function as light-driven proton pump. In other words, when proteorhodopsin is
bound to a retinal molecule and is exposed to light, a conformational change
occurs as it generates energy. Retinal is a derivative of vitamin A.
Proteorhodsopin is believed to serve as a possible alternative energy source that
could play an important role in the energy balance of the Earth. Proteorhodopsin
is widely distributed, and the bacteria containing it are some of the most prevalent
organisms on Earth. Proteorhodopsin has many potential uses and benefits in
commercial biotechnological applications and other industries. Also,
understanding the roles of pR in the oceanic food chain might help us to study
some significant impacts of global changes on marine communities and in the
ecosystem.

Unfortunately, ever since this particular protein has been discovered in 2000, it
has been difficult and challenging to obtain a well-defined three-dimensional
structure. Knowing the 3-D crystal structure of proteorhodopsin would
tremendously enhance a greater understanding in its functions and specific
physiological roles.

In order to obtain a well-defined three-dimensional structure, we have to form a
crystallized pR to perform x-ray crystallography – a method of determining the
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arrangement of atoms within a crystal – and crystallization requires a high pR
purity approximately 95% or greater.

Therefore, this project focused on establishing an optimized purification pR yield
by controlling specific conditions such as concentration, solubility, pH, and pRspecific precipitating agents. An understanding of the purification procedures of
proteorhodopsin could provide a better understanding in other various
transmembrane proteins, in particular the G protein-coupled receptors, which
constitute a large protein family of seven transmembrane receptors that activate
signal transduction pathways and cellular responses to pharmaceuticals.

Proteorhodopsin had been previously purified with columns and with other
materials that require both time and high cost. Professor Braiman and his
laboratory developed and established an invention for purifying pR using a simple
salt, sodium citrate, to precipitate pR selectively from a detergent extract of E.
coli cells. This particular method gave approximately 20-30% purity in a single
step, and is suitable for the preliminary purification.

In this project, we continued to explore a method that would increase the purity as
well as have the ability to reproduce a large quantity of pR. We expected that
another simple salt, phosphate, could help with selectively precipitating the
impurities from pR, which may increase the purity of pR. We have obtained
evidence that alternating treatment between citrate alone, and with citrate along
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with phosphate, may be a useful set of purification steps throughout this project.
The pR obtained from this purification procedure using citrate and phosphate
yields adequate quantity and purity of proteins that are suitable in techniques such
as SDS-PAGE (sodium dodecylsulfate polyacrylamide gel electrophoresis) and
UV/Visible absorption spectrum. This purification procedure of proteorhodopsin
is simple; it includes adding solution then centrifugation in order to selectively
precipitate impurities or pR. Purple pellets contain pR, and should be saved for
UV/Visible Spectroscopy for the examination of the degree of pR purity. The
advantage of using citrate and phosphate in pR purification is that they are
inexpensive materials, which reduce cost tremendously as it eliminates the use of
a column, but still has the ability to provide the same level of purity. This simple
purification method to purify pR proved less costly and more efficient. Also, this
method could possibly purify other transmembrane proteins (G protein-coupled
receptors), which would be enormously significant for pharmaceutical purposes.

This project should be continued to seek better conditions that would increase the
quantity of pR as well as purity. The pR purification procedure described in the
Capstone Project has shown potential, but needs further work. The ultimate goal
of the project is a well-defined three-dimensional structure of proteorhodopsin
and this work has brought us a step closer in achieving crystallization through
citrate and phosphate precipitation of pR.

